Management of ventricular arrhythmias. Detection, drugs, and devices

JAMA

Volumn 281, Issue 2, 1999, Pages 172-179

  Cannom, David S ^a,d   Prystowsky, Eric N ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST VINCENT HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENCAINIDE; FLECAINIDE; LIDOCAINE; MORACIZINE;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVERSION; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; HEART VENTRICLE ARRHYTHMIA; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 0033550474     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.2.172     Document Type: Article

References (73)

1. Kennedy HL, Underhill SJ. Frequent or complex ventricular ectopy in apparently healthy subjects. Am J Cardiol. 1976;38:141-148.
2. Kostis JB, McCrone K, Moreyra AE, et al. Premature ventricular complexes in the absence of identifiable heart disease. Circulation. 1981;63:1351-1356.
3. Prystowsky EN, Heger JJ, Zipes DP. The recognition and treatment of patients at risk for sudden death In: Eliot RS, Saenz A, Forker AD, eds. Cardiac Emergencies. Mount Kisco, NY: Futura Publishing Co; 1982: 353-384.
4. Ruberman W, Weinblatt E, Goldberg JD, et al. Ventricular premature beats and mortality after myocardial infarction. N Engl J Med. 1977;297:750-757.
5. Moss AJ, David HT, DeCamilla J, Bayer LW. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction. Circulation. 1979;60:988-997.
6. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971;44:130-142.
7. Lie KL, Wellens HJJ, Downar E, Durrer D. Observations on patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation. 1975;52:755-759.
8. Bigger JT, Weld FM. Analysis of prognostic significance of ventricular arrhythmias after myocardial infarction. Br Heart J. 1981;45:717-724.
9. Winkle RA, Derrington DC, Schroeder JS. Characteristics of ventricular tachycardia in ambulatory patients. Am J Cardiol. 1977;39:487-492.
10. Naccarelli GV, Prystowsky EN, Jackman WM, Heger JJ, Rinkenberger RL, Zipes DP. Repetitive ventricular response. Br Heart J. 1981;46:152-158.
11. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. Circulation. 1993;87:312-322.
12. Buxton AE, Fisher JD, Josephson ME, et al, and the MUSTT Investigators. Prevention of sudden death in patients with coronary artery disease. Prog Cardiovasc Dis. 1993;36:215-226.
13. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. JAMA. 1988;260:1910-1916.
14. Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med. 1989;149:2694-2698.
15. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-412.
16. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 1992;327:227-233.
17. Minardo JD, Heger JJ, Miles WM, Zipes DP, Prystowsky EN. Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy. N Engl J Med. 1988;319:257-262.
18. Stanton MS, Prystowsky EN, Fineberg NS, et al. Arrhythmogenic effects of antiarrhythmic drugs. J Am Coll Cardiol. 1989;14:209-215.
19. Anderson JL, Platia EV, Hallstrom A, et al, for the Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Interaction of baseline characteristics with the hazard of encainide, flecainide and moricizine therapy in patients with myocardial infarction. Circulation. 1994;90:2843-2852.
20. Prystowsky EN, Klein GJ. Cardiac Arrhythmias: An Integrated Approach for the Clinician. New York, NY: McGraw-Hill Book Co; 1994.
21. Prystowsky EN. Electrophysiologic-electropharmacologic testing in patients with ventricular arrhythmias. Pacing Clin Electrophysiol. 1988;11:225-251.
22. Fisher JD, Cohen HL, Mehra R, et al. Cardiac pacing and pacemakers, II. Am Heart J. 1977;93:658-668.
23. Haverkamp W, Martinez-Rubio A, Heif C, et al. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest. J Am Coll Cardiol. 1997;30:487-495.
24. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal sustained ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
25. Graboys TB, Lown B, Podrid PJ, DeSilva R. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol. 1982;50:437-443.
26. Mitchell LB, Duff JH, Manyari DE, Wyse DG. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. N Engl J Med. 1987;317:1681-1687.
27. Mason JW, for the Electrophysiologic Study Versus Electrocardiographic Monitoring Investigators. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med. 1993; 329:445-451.
28. Mason JW, for the Electrophysiologic Study Versus Electrocardiographic Monitoring Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med. 1993;329:452-458.
29. Prystowsky EN. Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM): a critical appraisal. Control Clin Trials. 1996;17(suppl):28S-36S.
30. Eisenberg MS, Horwood BT, Cummins RO, Reynolds-Haertle R, Hearne TR. Cardiac arrest and resuscitation. Ann Emerg Med. 1990;19:179-186.
31. Myerburg R, Kessler KM, Castellanos A. Sudden cardiac death. Ann Intern Med. 1993;119:1187-1197.
32. Moss AJ, Hall WJ, Cannom DS, et al, for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335: 1933-1940.
33. Domanski MJ, Zipes DP, Schron E. Treatment of sudden cardiac death. Circulation. 1997;95:2694-2699.
34. Prystowsky EN. Role of electrophysiologic testing prior to hospital discharge In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven Publishers; 1996:1257-1265.
35. Simson MB. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation. 1981; 64:235-242.
36. Gomes JA, Winters SL, Stewart D, et al. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction. J Am Coll Cardiol. 1987;10: 349-357.
37. Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious arrhythmic events after myocardial infarction. J Am Coll Cardiol. 1987;9:531-538.
38. Breithardt G, Cain ME, El-Sherif N, et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. J Am Coll Cardiol. 1991;17:999-1006.
39. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Circulation. 1996;93:1043-1065.
40. Katona PC, Jih F. Respiratory sinus arrhythmia. J Appl Physiol. 1975;39:801-805.
41. Katz A, Liberty IF, Porath A, et al. Simple bed-side test of one minute heart rate variability during deep breathing predicts mortality after myocardial infarction. Circulation. 1996;94:1-27.
42. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ, and the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
43. Raeder E, Rosenbaum DS, Bhasin R, et al. Alternating morphology of the QRST complex preceding sudden death. N Engl J Med. 1992;326:272-273.
44. Day CP, McComb JM, Campbell RWF. QT dispersion. Br Heart J. 1990;63:342-344.
45. Buja G, Miorelli M, Turrini P, et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol. 1993;72:973-977.
46. Mirowski M, Reid PR, Winkle RA, et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med. 1983;98:585-588.
47. Winkle RA, Mead RH, Ruder MA, et al. Long term outcome with the automatic implantable cardioverter defibrillator. J Am Coll Cardiol. 1989;13:1353-1361.
48. Thomas AC, Moser SA, Smutka ML, et al. Implantable defibrillation. Pacing Clin Electrophysiol. 1988;11:2053-2058.
49. Kelly PA, Cannom DS, Garan H, et al. The automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 1988;11:1278-1286.
50. Newman D, Suave MJ, Herre J, et al. Survival after implantation of a cardioverter defibrillator. Am J Cardiol. 1992;69:899-903.
51. Powell AC, Fuchs TE, Finkelstein DM, et al. Influence of implantable cardioverter defibrillators and long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation. 1993;88:1083-1092.
52. The PCD Investigators Group. Clinical article on patients with malignant ventricular tachyarrhythmias and a multi-programmable implantable cardioverter-defibrillator implanted with or without thoracotomy. J Am Coll Cardiol. 1994;23:1521-1530.
53. Hook BG, Marchlinski FE. Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. J Am Coll Cardiol. 1991;17:985-990.
54. Cox JL. Patient selection criteria and results of surgery for refractory ischemic ventricular tachycardia. Circulation. 1989;79(suppl):163-177.
55. Daoud E, Morady F. Catheter ablation of ventricular tachycardia. Curr Opin Cardiol. 1995;10:21-25.
56. Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88:1647-1670.
57. Blanchard SM, Walcott GP, Wharton JM, Ideker RE. Why is catheter ablation less successful than surgery for treating ventricular tachycardia that results from coronary artery disease? Pacing Clin Electrophysiol. 1994;17(pt 1):2315-2335.
58. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA. 1982;247:1707-1714.
59. Packer M, Bristow MR, Cohn JN, et al, for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
60. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-677.
61. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429-1435.
62. Kober L, Trop-Pederson C, Carlsen JE, et al, for the Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the ACE inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333:1670-1676.
63. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease. Lancet. 1994;344: 1383-1389.
64. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST segment elevation in leads V1 through V3. Circulation. 1998;97:457-460.
65. Krahn AD, Klein GJ, Yee R. Recurrent syncope. Cardiol Clin. 1997;15:313-326.
66. Kennedy HL, Whitlock JA, Sprague MK, et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med. 1985;312:193-197.
67. Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction. Lancet. 1997;349:667-674.
68. Cairns JA, Connolly SJ, Roberts R, et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations. Lancet. 1997;349:675-682.
69. Julian DG, Jackson FS, Prescott RJ, Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet. 1982;1:1142-1147.
70. Mitchell LB. Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhythmias. Curr Opin Cardiol. 1997;12:33-40.
71. Poole JE, Bardy GH. Sudden cardiac death. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology From Cell to Bedside. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1995:812.
72. Kelly P, Ruskin JN, Vlahakes GJ, et al. Surgical coronary revascularization in survivors of prehospital cardiac arrest. J Am Coll Cardiol. 1990;15:267-273.
73. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/ AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. J Am Coll Cardiol. 1998;31:1175-1209.